Close
Smartlab Europe
Achema middle east

News

Patient Blood Cells Get Rid of Tumour Through New Therapy

Adoptive cell therapy has gone on to become a promising immunotherapy tool that can be used to help in the treatment of advanced melanoma. The therapy, which makes use of the immune cells that are collected from the individual's...

Forecasting mRNA Degradation To Enhance Vaccine Stability

Messenger ribonucleic acid (mRNA) as a therapeutic method is gaining traction due to its ease of production and promising results. mRNA-based vaccines, for example, have been critical in the fight against COVID-19 in many parts of the world. Yet, because...

Randomized Trials Backed By FDA For Speedy Drug Approvals

In a significant update to its existing policies when it comes to conducting clinical trials so as to support an accelerated approval for oncology as well as other life-saving therapies, the FDA is planning a preference for randomised controlled...

Bladder Cancer Can Gain From Sustained-Release Chemotherapy

As reported by a study, a novel, sustained-release chemotherapy delivery device which is inserted in the bladder has gone on to facilitate the tumour response. The treatment was given to patients in the elderly bracket who had advanced bladder...

The Growing World of Pharma Cold Chain Logistics In Europe

In December, the European Commission went on to issue the first approval when it comes to allogenic T-cell therapy in the world, which happened to be a prominent milestone when it comes to the cell and gene therapy sector....

As Drug Shortages Rise, Pharma Supply Chain Poses Risks

Drug shortages endanger national security as well as public health. This is the conclusion of a new report from the United States Senate's Homeland Security Committee. As per the report, medicine shortages reached a five-year high of 295 in 2022,...

2031 To See World Cell, Gene Therapy Supply Chain Hit $3.12b

The global cell and gene therapy (CGT) supply chain and logistics industry is predicted to reach $3.12 billion by 2031, based on a market report. This equates to a very promising compound annual growth rate (CAGR) of 11.2% between 2023...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »